glp 1 drugs zepbound Eli Lilly to seek approval of new GLP-1 weight-loss drug this year Eli Lilly stock soars on

A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight loss

Last reviewed: May 25, 2026 Last updated: May 25, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Risks of diabetic foot syndrome and amputation associated with sodium glucose co-transporter 2 inhibitors: a meta-analysis of randomized controlled trials

34 Nearly similar pooled proportions of acute pancreatitis, ranging from 0.3% to 0.4%, were reported for all three doses

GLP-1 Receptor Agonists for obesity care Incretin hormones Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by enteroendocrine L-cells located in the distal small intestine and colon when nutrients are consumed [14, 15]

The straight answer: They're not going to work like prescription medications